Ranger Energy Services (NYSE:RNGR) announced a new agreement to provide three additional ECHO hybrid workover rigs to Hess Corporation (a subsidiary of Chevron (NYSE:CVX)), marking a continued expansion of its electrified rig fleet.
William Dudley, former president of the Federal Reserve Bank of New York and Bloomberg Opinion Columnist, says Federal Reserve Chairman Kevin Warsh has to communicate more with markets, or he'll become less influential. He appears on "Bloomberg Surveillance" to talk about Warsh's testimony before Congress.
Hemab Therapeutics (NASDAQ:COAG) shared Phase 2 long-term extension data for its drug candidate sutacimig, which demonstrated sustained prophylactic bleed reduction across 34 patients with Glanzmann thrombasthenia.
HCA Healthcare (NYSE:HCA) expects preliminary second-quarter revenue of $20.230 billion, an 8.7% increase from $18.605 billion in the same period of 2025.
IBM (NYSE:IBM) expects preliminary second-quarter revenue of $17.2 billion, up 1% but below analysts’ $17.86 billion estimate.
Bank of England Governor Andrew Bailey warned that the fallout from an artificial intelligence stocks bubble bursting would reach the UK economy and could prompt a response in interest rates. He made the comments during a testimony before Parliament's Treasury Committee.
America’s Car-Mart (NASDAQ:CRMT) reported fiscal 2026 revenue of $1.28 billion and a net loss of $16.79 per share.
Saul Martinez, Head of US Financials Research at HSBC, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the upcoming earnings season for major US banks.
Atrium Therapeutics (NASDAQ:RNA) received FDA clearance for its Investigational New Drug application to begin a 37-participant Phase 1/2 clinical trial.
Apollo Global Management President Jim Zelter says private capital is stepping in to fill a financing gap left by governments whose balance sheets can no longer support large-scale industrial capital expenditure. "Government pocketbooks aren't as buoyant to be able to provide that," Zelter tells Bloomberg Television.
Xanadu (NASDAQ:XNDU) and Lockheed Martin (NYSE:LMT) announced a strategic collaboration to expand internal quantum programming training.
Summit Therapeutics (NASDAQ:SMMT) sold its investigational Phase III precision antibiotic ridinilazole to Biossil for up to $105 million.
_1438935_640x360_2506480707900-640x360.webp&w=3840&q=75)
_1438899_640x360_2506481219636-640x360.webp&w=3840&q=75)
_1438892_640x360_2506479683829-640x360.webp&w=3840&q=75)
_1438881_640x360_2506475075976-640x360.webp&w=3840&q=75)
